Suppr超能文献

可溶性多聚谷氨酰胺寡聚物在活细胞中的形成与毒性。

Formation and toxicity of soluble polyglutamine oligomers in living cells.

机构信息

Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, New York, United States of America.

出版信息

PLoS One. 2010 Dec 28;5(12):e15245. doi: 10.1371/journal.pone.0015245.

Abstract

BACKGROUND

Aggregation and cytotoxicity of mutant proteins containing an expanded number of polyglutamine (polyQ) repeats is a hallmark of several diseases, including Huntington's disease (HD). Within cells, mutant Huntingtin (mHtt) and other polyglutamine expansion mutant proteins exist as monomers, soluble oligomers, and insoluble inclusion bodies (IBs). Determining which of these forms constitute a toxic species has proven difficult. Recent studies support a role for IBs as a cellular coping mechanism to sequester levels of potentially toxic soluble monomeric and oligomeric species of mHtt.

METHODOLOGY/PRINCIPAL FINDINGS: When fused to a fluorescent reporter (GFP) and expressed in cells, the soluble monomeric and oligomeric polyglutamine species are visually indistinguishable. Here, we describe two complementary biophysical fluorescence microscopy techniques to directly detect soluble polyglutamine oligomers (using Htt exon 1 or Htt(ex1)) and monitor their fates in live cells. Photobleaching analyses revealed a significant reduction in the mobilities of mHtt(ex1) variants consistent with their incorporation into soluble microcomplexes. Similarly, when fused to split-GFP constructs, both wildtype and mHtt(ex1) formed oligomers, as evidenced by the formation of a fluorescent reporter. Only the mHtt(ex1) split-GFP oligomers assembled into IBs. Both FRAP and split-GFP approaches confirmed the ability of mHtt(ex1) to bind and incorporate wildtype Htt into soluble oligomers. We exploited the irreversible binding of split-GFP fragments to forcibly increase levels of soluble oligomeric mHtt(ex1). A corresponding increase in the rate of IBs formation and the number formed was observed. Importantly, higher levels of soluble mHtt(ex1) oligomers significantly correlated with increased mutant cytotoxicity, independent of the presence of IBs.

CONCLUSIONS/SIGNIFICANCE: Our study describes powerful and sensitive tools for investigating soluble oligomeric forms of expanded polyglutamine proteins, and their impact on cell viability. Moreover, these methods should be applicable for the detection of soluble oligomers of a wide variety of aggregation prone proteins.

摘要

背景

含有多个聚谷氨酰胺(polyQ)重复的突变蛋白的聚集和细胞毒性是几种疾病的标志,包括亨廷顿病(HD)。在细胞内,突变亨廷顿蛋白(mHtt)和其他聚谷氨酰胺扩展突变蛋白以单体、可溶性寡聚物和不溶性包含体(IBs)的形式存在。确定这些形式中的哪一种构成毒性物种一直很困难。最近的研究支持 IBs 作为一种细胞应对机制,以隔离潜在毒性可溶性单体和寡聚体形式的 mHtt 的水平。

方法/主要发现:当与荧光报告器(GFP)融合并在细胞中表达时,可溶性单体和寡聚聚谷氨酰胺物种在视觉上无法区分。在这里,我们描述了两种互补的生物物理荧光显微镜技术,以直接检测可溶性聚谷氨酰胺寡聚物(使用 Htt 外显子 1 或 Htt(ex1)) 并监测它们在活细胞中的命运。光漂白分析显示,mHtt(ex1) 变体的迁移率显著降低,这与其掺入可溶性微复合物一致。同样,当与分裂 GFP 构建体融合时,野生型和 mHtt(ex1) 都形成寡聚物,这一点从荧光报告器的形成得到证明。只有 mHtt(ex1) 分裂 GFP 寡聚物组装成 IBs。FRAP 和分裂 GFP 方法都证实了 mHtt(ex1) 结合并将野生型 Htt 掺入可溶性寡聚物的能力。我们利用分裂 GFP 片段的不可逆结合来强制增加可溶性寡聚 mHtt(ex1) 的水平。观察到 IBs 形成的速率和形成的数量相应增加。重要的是,可溶性 mHtt(ex1) 寡聚物水平的升高与突变体细胞毒性的增加显著相关,与 IBs 的存在无关。

结论/意义:我们的研究描述了用于研究扩展聚谷氨酰胺蛋白的可溶性寡聚形式及其对细胞活力影响的强大而敏感的工具。此外,这些方法应该适用于检测各种易于聚集的蛋白质的可溶性寡聚物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a95/3011017/bc1971790a77/pone.0015245.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验